is tirzepatide coming off the shortage list A Major GLP-1 Drug Over. Some Patients Aren't Celebrating Compounded GLP-1s: What to Do

Moreover, renal cell death and tubular injury were also deceased in the intermittent hypoxia + ALA group, and treatment with ALA mitigated intermittent hypoxia-induced glomerular hypertrophy and decreased albuminuria [145]

Am J Kidney Dis 79:717727

The lack of follow-up of neonates born to women exposed to either GLP-1 agonists or SGLT2 inhibitors is a barrier to the study of potential adverse effects only apparent later in life

Reason being, dihydroberberine is naturally made in the human digestive tract as a berberine metabolite -- it's produced when the gut microbiome hydrogenates berberine so that it can absorb it